| 产品名称 | Peptides EP14602_1 | SARS-CoV-2 Nucleocapsid A2 N223-231 (HLA-A*02:01) |
|---|---|
| 目录号 | EP14602_1 |
| 别名 | SARS-CoV-2 Nucleocapsid A2 N223-231 (HLA-A*02:01) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| EP14602_1 | 1 mg; 5 mg | 咨询 | 咨询 |
Peptides EP14602_1 | SARS-CoV-2 Nucleocapsid A2 N223-231 (HLA-A*02:01)
品名：SARS-CoV-2 Nucleocapsid A2 N223-231 (HLA-A*02:01)
货号：EP14602_1
规格：1 mg; 5 mg
品牌：Peptides.de
产品描述
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike protein (S) and others. The nucleocapsid protein has different functions in the coronavirus replication cycle, for example the viral genome packaging. SARS-CoV Nucleocapsid A2 N223-231 (HLA-A*02:01) is a linear peptide derived from the N protein. In a recent study, LLLDRLNQL sequence was one of the T cell epitopes derived from the nucleocapsid (N) protein that mapped identically to SARS-CoV-2 protein. Immune targeting of these epitopes may potentially offer protection against this novel virus.
| Protein | Nucleoprotein |
| Species | SARS-CoV-2 |
| Application | Flow Cytometry |
| Indication | Infectious disease |
